A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of Onradivir Tablets in Participants Aged 12 to 17 Years With Uncomplicated Influenza A.

NCT07229547 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Influenza

Interventions

DRUG: Placebo
DRUG: Onradivir tablet

Sponsor

Ruijin Hospital